We are live on ! Find out more
FDCDDQ

Federation des caisses Desjardins du Quebec Portfolio holdings

AUM $27.8B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+31.66%
3 Year Est. Return
+71.4%
5 Year Est. Return
+81.76%
10 Year Est. Return
AUM
$9.08B
AUM Growth
+$635M
Cap. Flow
+$308M
Cap. Flow %
3.4%
Top 10 Hldgs %
24.14%
Holding
2,439
New
122
Increased
600
Reduced
773
Closed
91

Top Sells

Rank Stock Value
1
MFC icon
Manulife Financial
MFC
+$20.6M
2
AVGO icon
Broadcom
AVGO
+$18.2M
3
INTU icon
Intuit
INTU
+$17.2M
4
EWG icon
iShares MSCI Germany ETF
EWG
+$14.8M
5
NVDA icon
NVIDIA
NVDA
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 26.5%
2 Technology 13.35%
3 Communication Services 9.13%
4 Industrials 7.73%
5 Healthcare 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPL
2201
PPL Corp
PPL
$26.8B
$556 ﹤0.01%
20
FATE icon
2202
Fate Therapeutics
FATE
$294M
$542 ﹤0.01%
95
BDTX icon
2203
Black Diamond Therapeutics
BDTX
$116M
$529 ﹤0.01%
280
PLX icon
2204
Protalix BioTherapeutics
PLX
$190M
$525 ﹤0.01%
250
GTE icon
2205
Gran Tierra Energy
GTE
$336M
$523 ﹤0.01%
60
CYH icon
2206
Community Health Systems
CYH
$419M
$515 ﹤0.01%
105
SLVM icon
2207
Sylvamo
SLVM
$1.55B
$509 ﹤0.01%
11
BCEL
2208
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$502 ﹤0.01%
440
HSDT icon
2209
Solana Company
HSDT
$105M
0
LENZ
2210
LENZ Therapeutics
LENZ
$145M
$490 ﹤0.01%
29
GUT
2211
Gabelli Utility Trust
GUT
$580M
$486 ﹤0.01%
70
GRX
2212
Gabelli Healthcare & Wellness Trust
GRX
$147M
$484 ﹤0.01%
48
VJET
2213
DELISTED
VOXELJET AG American Depositary Shares (each representing one Ordinary Share)
VJET
$484 ﹤0.01%
230
MITK icon
2214
Mitek Systems
MITK
$853M
$480 ﹤0.01%
+50
New +$480
GGT
2215
Gabelli Multimedia Trust
GGT
$175M
$462 ﹤0.01%
83
BIV icon
2216
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$460 ﹤0.01%
6
DPRO
2217
Draganfly
DPRO
$170M
$460 ﹤0.01%
14
WE
2218
DELISTED
WeWork Inc.
WE
$451 ﹤0.01%
15
LAW icon
2219
CS Disco
LAW
$297M
$438 ﹤0.01%
66
SPCB icon
2220
SuperCom
SPCB
$70.3M
$432 ﹤0.01%
15
MVIS icon
2221
Microvision
MVIS
$89.7M
$427 ﹤0.01%
11
OCGN icon
2222
Ocugen
OCGN
$458M
$427 ﹤0.01%
500
SDGR icon
2223
Schrodinger
SDGR
$1.38B
$395 ﹤0.01%
15
GOEV
2224
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$392 ﹤0.01%
1
PDYNW icon
2225
Palladyne AI Corp Warrants
PDYNW
$209K
$385 ﹤0.01%
3,500

Similar funds

Federation des caisses Desjardins du Quebec's Q1 2023 Portfolio in Review

As of Q1 2023, Federation des caisses Desjardins du Quebec held 2,439 positions worth $9.08B, up 7.5% from $8.44B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Federation des caisses Desjardins du Quebec deployed $308M of net new capital in Q1 2023, opening 122 new positions and adding to 600 existing holdings. Its largest new stake was Royalty Pharma: 193,115 shares worth $6.96M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Manulife Financial, an estimated $20.6M trimmed.

  • Federation des caisses Desjardins du Quebec's largest Q1 2023 buy was Royalty Pharma: 193,115 shares worth $6.96M.
  • Federation des caisses Desjardins du Quebec added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $107M increase.
  • Federation des caisses Desjardins du Quebec's biggest Q1 2023 reduction was Manulife Financial, cutting an estimated $20.6M.
  • Federation des caisses Desjardins du Quebec fully exited Dimensional International Small Cap Value ETF in Q1 2023, selling an estimated $3.1M.
  • Federation des caisses Desjardins du Quebec's ten largest holdings make up 24% of its $9.08B portfolio in Q1 2023.
  • Federation des caisses Desjardins du Quebec opened 122 new positions and closed 91 in Q1 2023.
  • Federation des caisses Desjardins du Quebec's portfolio value rose 7.5% quarter-over-quarter to $9.08B.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2023, filed 15 Aug 2024.